Drug Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

Drug Name LVGN6051
Trade Name
Synonyms LVGN-6051|LVGN 6051
Drug Descriptions

LVGN6051 is a monoclonal antibody that targets 4-1BB (CD137) and acts as an agonist in the presence of Fc-gammaRIIB, potentially resulting in decreased tumor growth (PMID: 31105267).

DrugClasses TNFRSF9 Antibody 15
CAS Registry Number NA
NCIT ID C171541

Filtering

  • Case insensitive filtering will display rows where any text in any cell matches the filter term
  • Simple literal full or partial string matches
  • Separate multiple filter terms with a spaces, order doesn't matter (a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page, filtering has no impact on query parameters
  • Use quotes to match a longer phrase which contains spaces "mtor c1483f"

Sorting

  • Generally, the default sort order for tables is set to be first column ascending, however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column, be sure to set ascending or descending order for a given column, before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
Bevacizumab + Cyclophosphamide + LVGN3616 + LVGN6051 Bevacizumab Cyclophosphamide LVGN3616 LVGN6051 0 1
Bevacizumab + Cyclophosphamide + LVGN3616 + LVGN6051 + LVGN7409 Bevacizumab Cyclophosphamide LVGN3616 LVGN6051 LVGN7409 0 1
LVGN3616 + LVGN6051 + LVGN7409 + Nab-paclitaxel LVGN3616 LVGN6051 LVGN7409 Nab-paclitaxel 0 1
LVGN6051 LVGN6051 0 1
LVGN6051 + Pembrolizumab LVGN6051 Pembrolizumab 0 0


Additional content available in CKB BOOST